Bassam Abdulkarim Selected Research

Bassam Abdulkarim Research Topics

Disease

18	Neoplasms (Cancer) 02/2020 - 04/2002
11	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 08/2010
8	Breast Neoplasms (Breast Cancer) 01/2022 - 12/2006
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2021 - 01/2016
3	Brain Neoplasms (Brain Tumor) 12/2019 - 12/2006
2	Lung Neoplasms (Lung Cancer) 09/2021 - 01/2020
2	Neoplasm Metastasis (Metastasis) 02/2020 - 12/2006
2	Carcinogenesis 01/2019 - 05/2004
2	Glioma (Gliomas) 01/2018 - 10/2011
2	Carcinoma (Carcinomatosis) 10/2006 - 04/2002
1	Craniopharyngioma (Craniopharyngiomas) 05/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Triple Negative Breast Neoplasms 02/2020
1	COVID-19 01/2020
1	Infections 01/2017
1	Astrocytoma (Pilocytic Astrocytoma) 05/2014
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2006
1	Disease Progression 05/2004
1	Prostatic Neoplasms (Prostate Cancer) 05/2004
1	Retinoblastoma (Glioblastoma, Retinal) 04/2002
1	Squamous Cell Carcinoma of Head and Neck 04/2002

Drug/Important Bio-Agent (IBA)

6	Temozolomide (Temodar)FDA LinkGeneric 01/2022 - 02/2013
4	Trastuzumab (Herceptin)FDA Link 01/2019 - 11/2009
3	Biomarkers (Surrogate Marker)IBA 02/2020 - 11/2010
3	Proteins (Proteins, Gene)FDA Link 11/2018 - 11/2012
3	Cidofovir (Vistide)FDA Link 10/2006 - 04/2002
3	Antiviral Agents (Antivirals)IBA 10/2006 - 04/2002
2	DNA (Deoxyribonucleic Acid)IBA 12/2019 - 01/2018
2	Biological ProductsIBA 08/2019 - 11/2010
2	Epidermal Growth Factor (EGF)IBA 11/2018 - 11/2009
2	MethyltransferasesIBA 01/2018 - 11/2012
2	human ERBB2 proteinIBA 11/2009 - 12/2006
2	Oncogene Proteins (Oncogene Protein)IBA 04/2003 - 04/2002
1	Dihydrotachysterol (AT 10)IBA 01/2022
1	Metformin (Glucophage)FDA LinkGeneric 09/2021
1	Parathyroid Hormone-Related ProteinIBA 02/2020
1	epidermal growth factor receptor VIIIIBA 12/2019
1	ZR2002IBA 12/2019
1	eIF-2 Kinase (eIF 2 Kinase)IBA 01/2019
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2019
1	Activating Transcription Factor 4IBA 01/2019
1	Lapatinib (GW572016)FDA Link 11/2018
1	Pharmaceutical PreparationsIBA 11/2018
1	Junctional Adhesion Molecule AIBA 11/2018
1	Interleukin-8 (Interleukin 8)IBA 01/2018
1	Alkylating AgentsIBA 01/2018
1	NestinIBA 01/2018
1	O-(6)-methylguanineIBA 01/2018
1	EndonucleasesIBA 01/2018
1	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2018
1	Phenobarbital (Luminal)FDA Link 01/2013
1	Cysteine (L-Cysteine)FDA Link 11/2012
1	ParaffinIBA 11/2012
1	N-acetylaspartate (N-acetyl aspartate)IBA 10/2011
1	Choline (Choline Chloride)IBA 10/2011
1	Progesterone Receptors (Progesterone Receptor)IBA 11/2010
1	Estrogen ReceptorsIBA 11/2010
1	Tyrosine Kinase InhibitorsIBA 08/2010
1	Sunitinib (Sutent)FDA Link 08/2010
1	Angiogenesis InhibitorsIBA 08/2010
1	Small Interfering RNA (siRNA)IBA 11/2009
1	Monoclonal AntibodiesIBA 11/2009
1	ErbB Receptors (EGF Receptor)IBA 12/2006
1	Hormones (Hormone)IBA 12/2006
1	AndrogensIBA 05/2004
1	Organophosphonates (Phosphonates)IBA 04/2003
1	NucleosidesIBA 04/2003
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 04/2002

Therapy/Procedure

11	Radiotherapy 05/2022 - 10/2011
9	Therapeutics 02/2020 - 05/2004
2	Drug Therapy (Chemotherapy) 05/2014 - 11/2009
1	Chemoradiotherapy 09/2021
1	Adjuvant Chemotherapy 02/2020
1	Precision Medicine 01/2019
1	Operative Surgical Procedures 01/2017
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 02/2013